Charlotte McCormack

Charlotte McCormack serves as a key procurement professional within the National Institute on Drug Abuse (NIDA), supporting the agency’s mission to advance scientific research on substance use disorders and translate findings into clinical and public health applications. She manages a portfolio of scientific and technical service acquisitions, primarily overseeing contracts for research consulting, behavioral health studies, and neurobiological analysis services. Her work ensures that NIDA’s funding priorities are efficiently translated into contractor-delivered scientific capabilities, with a focus on high-impact, evidence-based research support. She plays a central role in aligning acquisition strategy with NIDA’s scientific goals, ensuring compliance with federal procurement regulations while facilitating timely access to specialized expertise. McCormack maintains consistent partnerships with leading academic medical institutions, including The McLean Hospital Corporation, the University of Maryland, Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These relationships are characterized by long-term, project-based engagements centered on translational research, clinical trial support, and behavioral science consulting. Her contracting patterns reflect a preference for established research entities with proven capacity in addiction science, neuroscience, and data analytics, indicating a focus on institutional expertise over commercial vendors. Her procurement activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on accessing the highest-caliber scientific talent, regardless of business size or certification status, prioritizing technical merit and research capability over socioeconomic preferences. Her primary procurement focus is under NAICS 541690—Other Scientific and Technical Consulting Services—encompassing expert advisory services, research design, data interpretation, and clinical implementation support in addiction science. She procures specialized scientific consulting to advance NIDA’s research agenda, particularly in neuroimaging, pharmacological interventions, and behavioral intervention development.